We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical.

Hamburg, DE

Key People at Evotec

Werner Lanthaler

Werner Lanthaler

Mario Polywka

Mario Polywka

Cord Dohrmann

Cord Dohrmann

Colin Bond

Colin Bond


Evotec Locations

Hamburg, DE
Branford, US
Princeton, US
Göttingen, DE
Toulouse, FR
Planegg, DE
Manchester, GB
South San Francisco, US
Milton, GB

Evotec Metrics

Evotec Summary

Founding Date


Market capitalization

€668 M

Closing share price


Evotec Market Value History

Evotec Company Life